• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Evaluation of the antimutagenic effect of (-)-epegallocatechin gallate (EGCG) against chemical-induced mutagenesis of transgenic HITEC mice

Research Project

Project/Area Number 09672206
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Biological pharmacy
Research InstitutionKanazawa University

Principal Investigator

YOKOI Tsuyoshi  Faculty of Pharmaceutical Sciences, Kanazawa University, Professor, 薬学部, 教授 (70135226)

Co-Investigator(Kenkyū-buntansha) KAMATAKI Tetsuya  Faculty of Pharmaceutical Sciences, Hokkaido University, Professor, 薬学部, 教授 (00009177)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 1998: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1997: ¥1,700,000 (Direct Cost: ¥1,700,000)
Keywordsepigallocatechin gallate / benzo[a]pyrene / mutagenesis / antimutagenesis / HITEC mouse / rpsL gene / 遺伝子損傷 / エピガロカテキンガレート
Research Abstract

The antimutagenic activity of epegallocatechin gallate (EGCG), the major water soluble compound of green tea, against benzo[a]pyrene (B[a]P)-induced mutations were assessed by using transgenic mice carrying rpsL gene as a monitor of somatic mutations (HITEC mice). EGCG has been known to inhibit cytochrome P450. Male mice of 7 weeks old were given drinking water containing EGCG for 3 weeks. On day 7, mice were treated with a single i.p. injection of B[alpha]P (500 mg/kg bwt). Two weeks after the injection the mutaion of rpsL gene were analyzed. B[a]P treatment resulted in the significant approximately 4Ofold increase of mutation frequency in the lung of HITEC mice. Approximately 60% suppression of B[a]P-induced mutations in the lung was observed when mice were given EGCG at concentraions higher than 0.005% EGCG.B[alpha]P-induced mutations mainly occurred at G : C base-pairs. The majority of base substitutions were G : C*C : G transversions, followed by G : C*T : A transversions and G : C*A : T transitions. B[a]P-induced mutations frequently occurred in the several specific nucleotide sequences of the rpsL gene. These were AGC, CGC, CGT, TGC and CGT ; all of them contained guanine residue. B[a]P-induced mutaions seen in the mouse ras codon 12 or human p53 codon 157 were found in the rpsL gene, and that the mutations were suppressed by EGCG for B[alpha]P-induced mutagenesis in vivo suggest that the drinking of tea may reduce the tumor-initiating potency of B[a]P in the lung.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (31 results)

All Other

All Publications (31 results)

  • [Publications] Yong Li et al.: "In vivo acivation of Aflatoxin B_1 in C57BL/6N mice carrying a human fetus-speficic CYP3A7 gene" Cancer Res.57. 641-645 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Katsunori Nakamura et al.: "Oxidation of hisamine H1 antagonist mequitazine is catalysed by cytochrome P450 2D6 in human liver microsomes" J.Pharmacol.Exp.Ther.284. 437-442 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ken-ichi Nunoya et al.: "A new deleted allele in human crtochrome P450 2A6 gene (CYP2A6) causing poor capaciry to metabolize SM-12502 in human liver microsomes" Pharmacogenetics. 8. 239-249 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kiyoshi Takasuna et al.: "Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of CPT-11 in rats" Cancer Chemother Pharmacol. 42. 280-286 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ayako Yamada et al.: "In vivo detection of mutations induced by aflatoxin B_1 using human CYP3A7/HITEC hybrid mice" Biochem.Biophys.Res.Com.250. 150-153 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Shigeharu Muto et al.: "Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice." Carcinogenesis. 20. 421-424 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yong Li, Tsuyoshi Yokoi, Motoya Katsuki, Jia-Sheng Wang, John D.Groopman and Tetsuya Kamataki: "In vivo acivation of Aflatoxin B1 in C57BL/6N mice carrying a human fetus-speficic CYP3A7 gene." Cancer Res.57. 641-645 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Takashi Iwatsubo, Hiroshi Suzuki, Noriaki Shimada, Kan Chiba, Takashi Ishizaki, Carol E.Green, Charles A.Tyson, Tsuyoshi Yokoi, Tetsuya Kamataki and Yuichi Sugiyama: "Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data using human liver microsomes and a recombinant system of human P450 isozymes." J.Pharmacol.Exp.Ther.282. 909-919 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Eiji Kashiyama, Tsuyoshi Yokoi, Masaaki Odomi, Yoshihiko Funae, Kazuaki Inoue and Tetsuya Kamataki: "Chtochrome P450 responsible for the stereoselective S-oxidations of flosequinan in hepatic microsemes." Drug Metab.Dispos.25. 716-724 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Katsunori Nakamura, Tsuyoshi Yokoi, Takao Kodama, Kazuaki Inoue, Kazuo Nagashima, Noriaki Shimada, Toshiaki Shimizu and Tetsuya Kamataki: "Oxidation of hisamine H1 antagonist mequitazine is catalysed by cytochrome P450 2D6 in human liver microsomes." J.Pharmacol.Exp.Ther.284. 437-442 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Minako Oshima, Tsuyoshi Yokoi, Philip Deitiker and M.Zouhair Atassi: "T cell responses in EAMG-susceptible and on-susceptible mouse strains agter immunization with overlapping peptides en compassing the extracellular part of Torpedo Californica acetylcholine receptor alpha chain. Implication to role in myasthnia gravis of autoimmune T-cell responses against receptor degradation products." Autoimmunity. 27. 79-90 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ken-ichi Nunoya, Tsuyoshi Yokoi, Kanzo Kimura, Kazuaki Inoue, Takao Kodama, Masato Funayama, Kazuo Nagashima, Yoshihiko Funae, Carol E.Green, Moritoshi Kinoshita and Tetsuya Kamataki: "A new deleted allele in human cytochrome P450 2A6 gene (CYP2A6) causing poor capacity to metabolize (+)-cis-3,5-dimethyl-2(3-pyridyl)thiazolidin-4-one hydrochroride (SM-12502) in human liver microsomes." Pharmacogenetics. 8. 239-249 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ayako Yamada, Ken-ichi Fujita, Tsuyoshi Yokoi, Shigeharu Muto, Akihiro Suzuki, Yoichi Gondoh, Motoya Katsuki and Tetsuya Kamataki: "In vivo detection of mutations induced by aflatoxin B1 using human CYP3A7/HITEC hybrid mice." Biochem.Biophys.Res.Com.250. 150-153 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kiyoshi Takasuna, Takehiro Hagiwara, Masaaki Hirohashi, Michiyuki Kato, Mamoru Nomura, Eiichi Nagai, Tsuyoshi Yokoi and Tetsuya Kamataki: "Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats." Cancer Chemother Pharmacol. 42. 280-286 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Shigeharu Muto, Tsuyoshi Yokoi, Yoichi Gondo, Motoya Katsuki, Ken-ichi Fujita and Tetsuya Kamataki: "Inhibition of benzo (a) pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice." Carcinogenesis. 20. 4210-424 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ken-ichi Nunoya, Tsuyoshi Yokoi, Yuki Takahashi, Kanzo Kimura, Kinoshita Moritoshi and Tetsuya Kamataki: "Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of entire CYP2A6 gene associated with the poor metabolizers." J.Pharmacol.Exp.Ther.(in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Miki Nakajima, Tsuyoshi Yokoi, Mayumi Mizutani, Moritoshi Kinoshita, Masato Funayama and Tetsuya Kamataki: "Genetic polymorphism in the 5'-flanking regin of human CYP1A2 gene : effect on the CYP1A2 inducibility in humans." J.Biochemistry. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Michihiro Chida, Tsuyoshi Yokoi, Nobuo Nemoto, Makoto Inaba, Moritoshi Kinoshita and Tetsuya Kamataki: "A new variant CYP2D6 alle (CYP2D6/C8) with a single base insetion in exon 5 in a Japanese population associated with the poor metabolizer phenotype." Pharmacogenetics. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Michihiro Chida, Tsuyoshi Yokoi, Yasuyuki Kosaka, Kan Chiba, Hidefumi Nakamura, Takashi Ishizaki, Jun Yokota, Moritoshi Kinoshita, Kunio Sato, Minoru Inaba, Yasuhiro Aoki, Frank J.Gonzalez and Tetsuya Kamataki: "Genetic polymorphism of CYP2D6 in Japanese population." Pharmacogenetics. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yong Li et al.: "In vivo acivation of Aflatoxin B_1 in C57BL/6N mice carrying a human fetus-speficic CYP3A7 gene" Cancer Res.57. 641-645 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Katsunori Nakamura et al.: "Oxidation of hisamine H1 antagonist mequitazine is catalysed by cytochrome P450 2D6 in human liver microsomes" J.Pharmacol.Exp.Ther.284. 437-442 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ken-ichi Nunoya et al.: "A new deleted allele in human cytochrome P450 2A6 gene(CYP2A6) causing poor capacity to metabolize SM-12502 in human liver microsomes" Pharmacogenetics. 8. 239-249 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kiyoshi Takasuna et al.: "Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of CPT-11 in rats" Cancer Chemother Pharmacol. 42. 280-286 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ayako Yamada et al.: "In vivo detection of mutations induced by aflatoxin B_1 using human CYP3A7/HITEC hybrid mice" Biochem.Biophys.Res.Com.250. 150-153 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Shigeharu Muto et al.: "Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice." Carcinogenesis. 20. 421-424 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yong Li: "In vivo acivation of Aflatoxin B1 in C57BL/6N mice carrying a human fetus-speticic CYP3A7 gene" Cancer Research. 57. 641-645 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] T.Iwatsubo: "Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data using human liver microsomes and a recombinant system of human P450 isozymes." J.Pharamcol. Exp. Ther.282. 909-919 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] E.Kashiyama: "Chtochrome P450 responsible for the stereoselective S-oxidations of flosequinan in hepatic microsemes" Drug Metab. Dispos.25. 716-724 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] K.Nakamura: "Mequitazine oxidation is catalysed by CYP2D6 in human liver microsomes" J.Pharmacol. Exp. Ther.(in press).

    • Related Report
      1997 Annual Research Report
  • [Publications] K.Nunoya: "A new deleted allele in human cytochrome P450 2A6 gene (CYP2A6) causing poor capacity to metabolize (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochroride (SM-12502) in human liver microsomes" Pharmacogenetics. (in press).

    • Related Report
      1997 Annual Research Report
  • [Publications] 横井毅: "抗癌剤の相互作用" 医薬ジャーナル社, 223 (1998)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi